Company profile: Outpace Bio
1.1 - Company Overview
Company description
- Provider of innovative cell therapies designed to enhance cancer treatment efficacy.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Outpace Bio
TScan
HQ: United States
Website
- Description: Provider of TCR-T immunotherapies and platforms for cancer, including TSC-100 and TSC-101 targeting minor histocompatibility antigens HA-1 and HA-2 for post-transplant hematologic malignancies. Offers ImmunoBank of therapeutic TCRs for multiplexed solid tumor therapies, plus TargetScan, ReceptorScan, SafetyScan, and T-Integrate for target discovery, safety screening, and non-viral manufacturing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TScan company profile →
CytoSolv
HQ: United States
Website
- Description: Provider of wound care technology focused on the treatment of diabetic ulcers and other wounds, developing solutions aimed at curing diabetic ulcers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CytoSolv company profile →
California Stem Cell
HQ: United States
Website
- Description: Provider of high-purity human cells for therapeutic development and clinical applications, leveraging proprietary methods for scalable production of human motor neurons, neuronal progenitors, cardiac muscle, and sino-atrial node cells. Privately held; founded in 2005.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full California Stem Cell company profile →
Universal Cells
HQ: United States
Website
- Description: Provider of nuclease-free rAAV gene editing technology to create universal donor pluripotent and engineered allogeneic stem cells, and cell production for clinical trials. Develops, licenses and commercializes stem cell therapies designed to overcome immune rejection and enable true off-the-shelf therapeutic products using a proprietary genome editing approach.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Universal Cells company profile →
Neurona Therapeutics
HQ: United States
Website
- Description: Provider of cell therapies for neurological disorders, including NRTX-1001, a one-time dose therapy for drug-resistant focal epilepsy using human MGE-type inhibitory GABAergic interneurons derived from pluripotent stem cells; myelinating glial cell therapy using human oligodendrocytes to restore myelin; and gene-edited neural cell therapies for targeted delivery to the CNS.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Neurona Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Outpace Bio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Outpace Bio
2.2 - Growth funds investing in similar companies to Outpace Bio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Outpace Bio
4.2 - Public trading comparable groups for Outpace Bio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →